ArticleOTO open
Over-the-Counter Medications for Sinus Headache: A Cross-Sectional Survey Study.
Article in OTO open. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Objective: Sinus headache is a common complaint that can be due to chronic rhinosinusitis (CRS) or non-rhinogenic facial pain/pressure (NRFP). The purpose of this study is to characterize over-the-counter (OTC) medications used for sinus headache. Study Design: Cross-sectional study. Setting: Tertiary care academic center. Methods: Patients presenting with midfacial pain or pressure to a rhinology clinic were surveyed on how often they utilized common OTC medications, with choices ranging from "always" to "never." Patients were categorized into CRS or NRFP groups based on endoscopy and imaging. Results: The study included 251 patients, with 69.3% female and a mean (standard deviation) age of 49.9 (15.7) years. Patients with CRS (n = 114) reported symptom relief "sometimes" to "always" when using pain relievers (38.6%), intranasal steroids (37.7%), and oral antihistamines (36%). Patients with NRFP (n = 137) responded "sometimes" to "always" with the use of intranasal steroids (49.6%), decongestants (48.9%), and pain relievers (45.3%). A greater proportion of NRFP patients responded "sometimes" to "always" for decongestants to relieve symptoms compared to CRS patients ( Conclusion: Patients with midfacial pain or pressure reported using a variety of OTC medications for symptomatic relief. Decongestants were more frequently associated with symptom improvement in patients with NRFP. This finding indicates that symptomatic relief with decongestants may suggest a diagnosis of NRFP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.